R. Barni

Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patients.

C. Lombardo, C. Gambacorti-Passerini, F. Ravagnani, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Sensitivity to the abl inhibitor STI571 in fresh leukaemic cells obtained from chronic myelogenous leukaemia patients in different stages of disease

F. Rossi, C. Gambacorti-Passerini, E. Marchesi, 2001, British journal of haematology.

Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification.

M. Varella‐Garcia, R. Supino, C. Gambacorti-Passerini, 2000, Blood.

Role of (cid:1) 1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL + Leukemic Cells to the Abl Inhibitor STI571

M. Zucchetti, J. Brueggen, R. Cozens, 2000 .

Role of (cid:1) 1 Acid Glycoprotein in the In Vivo Resistance of Human BCR-ABL + Leukemic Cells to the Abl Inhibitor STI571

M. Zucchetti, R. Cozens, M. D’Incalci, 2022 .